Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, January 2002, p. 101-104, Vol. 46, No. 1
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.46.1.101-104.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Single-Dose Intraperitoneal Magainins Improve Survival in a Gram-Negative-Pathogen Septic Shock Rat Model
Oscar Cirioni,1,2* Andrea Giacometti,1 Roberto Ghiselli,2 Federico Mocchegiani,2 Anna Fineo,1 Fiorenza Orlando,3 Maria Simona Del Prete,1 Marco Rocchi,4 Vittorio Saba,2 and Giorgio Scalise1
Institute of Infectious Diseases and Public Health, University of Ancona,2
Department of General Surgery 1,2
Biotechnology Centre, Research Department, INRCA IRRCS, University of Ancona, Ancona,3
Institute of Biomathematics, Faculty of Pharmacy, University of Urbino, Urbino, Italy4
Received 2 July 2001/
Returned for modification 15 August 2001/
Accepted 5 October 2001
The therapeutic efficacies of three polycationic peptides selected among the class of the magainins (magainin I, magainin II, and magainin II amide), alone and combined with piperacillin, were investigated in a rat model of septic shock. Rats were given an intraperitoneal injection of 2 x 1010 CFU of Escherichia coli and randomized to receive intraperitoneally isotonic sodium chloride solution, 60 mg of piperacillin per kg of body weight, and 1 mg of each magainin per kg alone and combined with 60 mg of piperacillin per kg. The main outcome measures were bacterial growth in abdominal exudate and plasma, endotoxin and tumor necrosis factor alpha (TNF-
) concentrations in plasma, and lethality. Treatments with the magainins achieved significant reductions of bacterial growth and plasma endotoxin and TNF-
concentrations. In general, treatments with the combinations of magainins and piperacillin demonstrated the highest efficacies.
* Corresponding author. Mailing address: Clinica delle Malattie Infettive, c/o Ospedale Regionale, via Conca, 60020 Ancona, Italy. Phone: 39 071 5963715. Fax: 39 071 5963468. E-mail:
anconacmi{at}interfree.it.
Antimicrobial Agents and Chemotherapy, January 2002, p. 101-104, Vol. 46, No. 1
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.46.1.101-104.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Andra, J., Gutsmann, T., Garidel, P., Brandenburg, K.
(2006). Invited review: Mechanisms of endotoxin neutralization by synthetic cationic compounds. Innate Immunity
12: 261-277
[Abstract]
-
Giacometti, A., Ghiselli, R., Cirioni, O., Mocchegiani, F., D'Amato, G., Orlando, F., Sisti, V., Kamysz, W., Silvestri, C., Naldoski, P., Lukasiak, J., Saba, V., Scalise, G.
(2004). Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models. J Antimicrob Chemother
54: 654-660
[Abstract]
[Full Text]
-
Braunstein, A., Papo, N., Shai, Y.
(2004). In Vitro Activity and Potency of an Intravenously Injected Antimicrobial Peptide and Its DL Amino Acid Analog in Mice Infected with Bacteria. Antimicrob. Agents Chemother.
48: 3127-3129
[Abstract]
[Full Text]
-
Giacometti, A, Cirioni, O, Ghiselli, R, Mocchegiani, F, D'Amato, G, Del Prete, M S., Orlando, F, Kamysz, W, Lukasiak, J, Saba, V, Scalise, G
(2003). Administration of protegrin peptide IB-367 to prevent endotoxin induced mortality in bile duct ligated rats. Gut
52: 874-878
[Abstract]
[Full Text]
-
Ingham, A., Ford, M., Moore, R. J., Tizard, M.
(2003). The bacteriocin piscicolin 126 retains antilisterial activity in vivo. J Antimicrob Chemother
51: 1365-1371
[Abstract]
[Full Text]